Current Treatment Options in Oncology

Papers
(The median citation count of Current Treatment Options in Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Metabolic Aspects of Anthracycline Cardiotoxicity58
Models of Integration of Specialized Palliative Care with Oncology48
Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy45
Systemic Therapy for Metastatic Pancreatic Cancer42
Optimal Strategies for Colorectal Cancer Screening38
The Importance of Prognostication: Impact of Prognostic Predictions, Disclosures, Awareness, and Acceptance on Patient Outcomes38
Understanding and Supporting Informal Cancer Caregivers35
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms35
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma32
Defining and Targeting BRAF Mutations in Solid Tumors31
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects31
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer30
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies28
Appropriate Selection of PARP Inhibitors in Ovarian Cancer28
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy28
Immunotherapy in Hepatocellular Carcinoma27
BRAF Heterogeneity in Melanoma26
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives25
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment25
Cardiovascular Toxicities of Androgen Deprivation Therapy24
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past24
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer24
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches24
Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities23
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy23
Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments22
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer20
Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?20
Janus Kinase Inhibitors and Non-Melanoma Skin Cancer20
Constipation in Cancer Patients — an Update of Clinical Evidence20
Evaluation and Management of Sleep and Circadian Rhythm Disturbance in Cancer19
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma19
Systemic Options for Malignant Peripheral Nerve Sheath Tumors19
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?19
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma18
Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation18
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?18
Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors17
New Approaches to Myelodysplastic Syndrome Treatment17
Family Meetings in Palliative Care: Benefits and Barriers17
Progress on Management of Penile Cancer in 202017
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms16
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer16
Immunotherapy and Biomarkers in Sarcoma16
The Benefits of Olanzapine in Palliating Symptoms16
Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development16
Current Status of CAR T Cell Therapy for Leukemias16
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)15
Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma15
Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas15
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives15
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis15
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients14
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light14
Treating Chronic Pain with Buprenorphine—The Practical Guide14
Advanced Acral Melanoma Therapies: Current Status and Future Directions14
Management of Functional Pancreatic Neuroendocrine Neoplasms14
HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles14
Management of Laryngeal Dysplasia and Early Invasive Cancer14
Symptom Management in Pancreatic Cancer14
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?14
Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials14
HER2-Low Breast Cancer: a New Subtype?14
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy14
Treatment Strategies for Oligometastatic Breast Cancer13
Systemic Therapy for Lung Cancer Brain Metastases13
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities13
Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time13
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy13
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer13
New Immuno-oncology Targets and Resistance Mechanisms12
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations12
Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges12
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?12
Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma12
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?12
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy12
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer12
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer12
Treatment Approach to Adenocarcinoma of the Ampulla of Vater12
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma12
Drug Repurposing in Medulloblastoma: Challenges and Recommendations12
The Role of Pharmacogenomics in Opioid Prescribing12
Nectin-4: a Novel Therapeutic Target for Skin Cancers12
Targeted Therapy for Melanomas Without BRAF V600 Mutations11
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies11
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now11
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers11
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity11
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease11
BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia11
Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer11
Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer10
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure10
Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach10
Tailoring Treatment for Patients with Inflammatory Breast Cancer10
Novel Estrogen Receptor-Targeted Agents for Breast Cancer10
New Treatment Strategies for the Inflammatory Breast Cancer10
Surgical Management of Skull Base and Spine Chordomas10
Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma10
Treatment personalization in gastrointestinal neuroendocrine tumors10
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)10
New Treatment Options for Older Patients with Acute Myeloid Leukemia10
Approach to Localized Squamous Cell Cancer of the Esophagus10
Options for the Treatment of Mucinous Ovarian Carcinoma10
An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN)9
Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective9
Postoperative Management of Salivary Gland Tumors9
Which FLT3 Inhibitor for Treatment of AML?9
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers9
Myxoid Liposarcoma: How to Stage and Follow9
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review9
Management of Cutaneous Angiosarcoma: an Update Review9
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer9
Drug Development in Neuroendocrine Tumors: What Is on the Horizon?9
A Review of Pharmacologic Management in the Treatment of Mesothelioma9
The Role of Radiation Therapy for Symptomatic Desmoid Tumors9
Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead9
Systemic Therapy for Chondrosarcoma9
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma9
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?9
Frontiers of Ovarian Carcinosarcoma8
Surgical Management of Metastatic Gastrointestinal Stromal Tumors8
Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA8
Immunotherapy in HPV-Related Oropharyngeal Cancers8
Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer8
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?8
Myxoid Liposarcomas: Systemic Treatment Options8
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome8
Autophagy Paradox: Strategizing Treatment Modality in Melanoma8
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives8
The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer8
Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility8
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia8
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy8
Molecular-Driven Therapy in Advanced Thyroid Cancer8
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)8
The Role of Immunotherapy in the Treatment of Anal Cancer and Future Strategies8
Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer8
Approach to Resectable Biliary Cancers8
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia8
State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors8
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T8
Treatment Landscape of Renal Cell Carcinoma8
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?8
Novel Therapies in the Treatment of Hodgkin Lymphoma8
Management of Fatigue in Patients with Advanced Cancer7
Surgery Matters: Progress in Surgical Management of Gastric Cancer7
Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence7
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer7
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions7
Circulating Biomarkers for Cardiotoxicity Risk Prediction7
Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia7
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant Treatment7
Update of Diagnosis and Targeted Therapy for ALK+ Inflammation Myofibroblastic Tumor7
Targeting HIF-2 Alpha in Renal Cell Carcinoma7
Novel Approaches for the Treatment of Patients with Richter’s Syndrome7
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?7
The Importance of Primary Care in Cardio-Oncology7
Progress in the Treatment of Small Intestine Cancer7
Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma7
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges7
Targeted Therapy in Early Stage Non-small Cell Lung Cancer7
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?6
Cancer Therapies and Vascular Toxicities6
Targeted Therapy for BRAF Mutant Brain Tumors6
Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: “Care Anywhere, Anytime”6
Central Nervous System Lymphoma: Novel Therapies6
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours6
Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases6
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy6
Recognition and Management of the Long-term Effects of Cranial Radiation6
Desmoid Tumors: Current Perspective and Treatment6
Current Management and Treatment of Extramammary Paget’s Disease6
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas6
Non-Surgical Therapeutic Strategies for Non-Melanoma Skin Cancers6
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic6
Central Nervous System Prophylaxis and Treatment in Acute Leukemias6
COVID-19 and Gynecologic Oncology: What Have We Learned?6
Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence6
The Evolving Treatment Landscape of Merkel Cell Carcinoma6
Radical Hysterectomy After the LACC Trial: Back to Radical Vaginal Surgery6
Effects of Opioids on Immune and Endocrine Function in Patients with Cancer Pain6
Dermatofibrosarcoma Protuberans in Children6
Advances in Organ Preservation for Laryngeal Cancer6
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer6
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia6
The Role of Induction Therapy for Sinonasal Cancers5
Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?5
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma5
Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer5
Treatment Strategies for Malignancies of the External Auditory Canal5
How to Sequence Therapies in Mycosis Fungoides5
Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer5
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?5
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies5
The Current Landscape of Research Advocacy and Education for Patients with Colorectal Cancer5
How to Sequence Therapies in Waldenström Macroglobulinemia5
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies5
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)5
Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?5
Pathogenic Mechanisms in Acute Myeloid Leukemia5
The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective5
Can Immune Therapy Cure Acute Myeloid Leukemia?5
Guidance for Treating the Older Adults with Colorectal Cancer5
Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun5
Immunotherapy in AL Amyloidosis5
Role of Radiation Therapy for Newly Diagnosed Retroperitoneal Sarcoma5
Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance5
Overview and Emerging Trends in the Treatment of Osteoradionecrosis5
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?4
An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)4
The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer4
Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy4
An Update on Temporal Bone Paragangliomas4
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission4
Clinical Trial Considerations in Neuro-oncology4
Bone Morphogenic Protein Signaling and Melanoma4
Current Management of Chronic Neutrophilic Leukemia4
Cardio-oncology Training in the COVID-19 Era4
Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma4
Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments4
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?4
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming4
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy4
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer4
Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?4
How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia4
The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours4
Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach4
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer4
Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies4
Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk4
Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice4
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation4
Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?4
The Intersection of Prostate Cancer and Hypertension: a Call to Action4
A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies4
Sequencing of Novel Therapies for Mantle Cell Lymphoma4
Current Considerations in the Treatment of Grade 3 Gliomas4
Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options4
Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer4
0.092222929000854